Article

FDA to allow inserts for keratoconus patients

Des Plaines, IL-Micro-thin prescription inserts (Intacs, Addition Technology Inc.) may be used to reduce or eliminate myopia and astigmatism in patients with keratoconus for whom restoration of functional vision is no longer possible with contact lenses or glasses, under a new designation by the FDA.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
(Image credit: Ophthalmology Times) AGS 2025: Telemedicine and genetics for resource-efficient care with Louis R. Pasquale, MD
© 2025 MJH Life Sciences

All rights reserved.